These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 182362)

  • 1. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic requirements for hormone-induced resistance to antibody-complement mediated killing of tumor cells.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1977 Sep; 119(3):789-94. PubMed ID: 894026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.
    Ohanian SH; Borsos T
    J Immunol; 1975 Apr; 114(4):1292-5. PubMed ID: 163862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of concanavalin A on the killing of tumor cells by antibody and complement.
    Boyle MD; Langone JJ; Ohanian SH; Borsos T
    J Immunol; 1977 May; 118(5):1626-30. PubMed ID: 192797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of tumor cells by antibody and complement. VI. Enhanced killing of enzyme-pretreated tumor cells.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Mar; 116(3):661-8. PubMed ID: 176270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hormones on the killing by antibody and complement of tumor cells treated with proteolytic enzymes.
    Schlager SI; Ohanian SH; Borsos T
    Immunopharmacology; 1979 Mar; 1(2):115-24. PubMed ID: 400472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the synthesis and release of lipids in tumor cells under attack by antibody and C.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1978 Mar; 120(3):895-901. PubMed ID: 632591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 2):326-30. PubMed ID: 1167878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1.
    Boyle MD; Langone JJ
    J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1975 Aug; 115(2):473-5. PubMed ID: 50364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysis of tumor cells by antibody and complement. VII. Complement-dependent 86Rb release--a nonlethal event?
    Boyle MD; Ohanian SH; Borsos T
    J Immunol; 1976 Oct; 117(4):1346-50. PubMed ID: 185297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally soluble tumor antigens from guinea pig hepatomas: isolation and partial characterization.
    Detrick-Hooks B; Smith HG; Bast RC; Dunkel VC; Borsos T
    J Immunol; 1976 May; 116(5):1324-31. PubMed ID: 178795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and chemical composition of subcellular fractions from tumor cells treated with metabolic inhibitors or hormones.
    Schlager SI; Ohanian SH
    Cancer Res; 1979 Apr; 39(4):1369-76. PubMed ID: 421220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a TL(+) murine leukemia cell line that resists the cytotoxic effects of guinea pig complement and specific antiserum.
    Yu A; Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):299-308. PubMed ID: 51085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific and forssman antigens of guinea-pig hepatoma cells: comparison of tumor cells grown in vivo and in vitro.
    Evans CH; Ohanian SH; Cooney AM
    Int J Cancer; 1975 Mar; 15(3):512-21. PubMed ID: 166937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.